Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Prognostic Significance of Preoperative Serum Alpha-fetoprotein in Hepatocellular Carcinoma and Correlation with Clinicopathological Factors: a Single-center Experience from China

  • An, Song-Lin (Department of Abdominal Surgical Oncology, State Key Laboratory of Molecular Oncology, Cancer Institute and Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences) ;
  • Xiao, Ting (Department of Etiology and Carcinogenesis, State Key Laboratory of Molecular Oncology, Cancer Institute and Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences) ;
  • Wang, Li-Ming (Department of Abdominal Surgical Oncology, State Key Laboratory of Molecular Oncology, Cancer Institute and Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences) ;
  • Rong, Wei-Qi (Department of Abdominal Surgical Oncology, State Key Laboratory of Molecular Oncology, Cancer Institute and Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences) ;
  • Wu, Fan (Department of Abdominal Surgical Oncology, State Key Laboratory of Molecular Oncology, Cancer Institute and Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences) ;
  • Feng, Li (Department of Abdominal Surgical Oncology, State Key Laboratory of Molecular Oncology, Cancer Institute and Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences) ;
  • Liu, Fa-Qiang (Department of Abdominal Surgical Oncology, State Key Laboratory of Molecular Oncology, Cancer Institute and Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences) ;
  • Tian, Fei (Department of Abdominal Surgical Oncology, State Key Laboratory of Molecular Oncology, Cancer Institute and Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences) ;
  • Wu, Jian-Xiong (Department of Abdominal Surgical Oncology, State Key Laboratory of Molecular Oncology, Cancer Institute and Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences)
  • Published : 2015.06.03
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: To investigate the prognosis significance of preoperative serum alpha-fetoprotein (AFP) and the correlation with clinicopathological factors of hepatocellular carcinoma (HCC) patients who underwent hepatectomy. Materials and Methods: Clinicopathological data of retrospective analysis were collected for 251 HCC patients undergoing hepatectomy in this study. According to preoperative AFP level, patients were categorized into AFP-negative (0-20ng/mL) and AFP-positive (>20 ng/mL) groups for Kaplan-Meier analysis and Cox proportional hazard regression modeling. Results: The results demonstrated that increased AFP was associated with longer prothrombin time (PTs), liver capsule invasion, low grade differentiation, and late Barcelona Clinic Liver Center (BCLC) stage. Moreover, the female patients had a greater prevalence of increased preoperative AFP than male patients [284.8 (3.975-3167.5) vs (3.653-140.65); Z-2.895, p=0.004]. The 1-, 3-, and 5-year recurrence-free survival (RFS) rates were 78.1, 57.5, and 40.6 % in the AFP-negative group and 61.8, 37.7, and 31.4 %, respectively, in the AFP-positive group (log-rank test 8.312, p=0.004). The 1-, 3-, and 5-year overall survival (OS) rates were 94.4, 83.8, and 62.3% in the AFP-negative group and 87.2, 60.0, and 36.7%, respectively, in the AFP-positive group. The difference was statistically significant (log-rank test, 16.884, p=0.000). Cox proportional-hazards model identified preoperative AFP to be an independent prognostic predictor of overall survival. Conclusions: Preoperative serum AFP is an independent predictor of prognosis among HCC patients following surgical resection. Female patients have a higher preoperative AFP than their male counterparts.

Keywords

References

  1. Bertino G, Neri S, Bruno CM, et al (2011). Diagnostic and prognostic value of alpha-fetoprotein, des-${\gamma}$-carboxy prothrombin and squamous cell carcinoma antigen immunoglobulin M complexes in hepatocellular carcinoma. Minerva Med, 102, 363-71.
  2. Bois-Joyeux B, Danan JL (1994). Members of the CAAT/enhancer binding protein, hepatocyte nuclear factor-1 and nuclear factor-1 families can differentially modulate the activities of the rat alpha fetoprotein promoter and enhancer. Biochem J, 301, 49-55. https://doi.org/10.1042/bj3010049
  3. Bosetti C, Levi F, Boffetta P, et al (2008). Trends in mortality from hepatocellular carcinoma in Europe, 1980-2004. Hepatology, 48, 137-45. https://doi.org/10.1002/hep.22312
  4. Center MM, Jemal A (2011). International trends in liver cancer incidence rates. Cancer Epidemiol Biomarkers Prev, 20, 2362-8. https://doi.org/10.1158/1055-9965.EPI-11-0643
  5. Chan SL, Chan AT, Yeo W (2009). Role of alpha-fetoprotein in hepatocellular carcinoma: prognostication, treatment monitoring or both? Future Oncol, 5, 889-99. https://doi.org/10.2217/fon.09.64
  6. Crowe AJ, Sang L, Li KK, et al (1999). Hepatocyte nuclear factor 3 relieves chromatin-mediated repression of the alphafetoprotein gene. J Biol Chem, 274, 25113-20. https://doi.org/10.1074/jbc.274.35.25113
  7. Debruyne EN, Delanghe JR (2008). Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: new aspects and applications. Clin Chim Acta, 395, 19-26. https://doi.org/10.1016/j.cca.2008.05.010
  8. El-Serag HB (2011). Hepatocellular carcinoma. N Engl J Med, 365, 1118-27. https://doi.org/10.1056/NEJMra1001683
  9. Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127, 2893-917. https://doi.org/10.1002/ijc.25516
  10. Forner A, Vilana R, Ayuso C, et al (2008). Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology, 47, 97-104.
  11. Giannini EG, Marenco S, Borgonovo G, et al (2012). Alphafetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis. Hepatology, 56, 1371-9.
  12. Gupta S, Bent S, Kohlwes J (2003). Test characteristics of alpha fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A systematic review and critical analysis. Ann Intern Med, 139, 46-50. https://doi.org/10.7326/0003-4819-139-1-200307010-00012
  13. Haibin Z, Yue J, Yaxian X (2010). Primary yolk sac tumor of the omentum: a case report and literature review. Eur J Gynaecol Oncol, 31, 682-4.
  14. Ikai I, Arii S, Kojiro M, et al (2004). Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey. Cancer, 101, 796-802. https://doi.org/10.1002/cncr.20426
  15. Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
  16. Kim do Y, Han KH (2012). Epidemiology and surveillance of hepatocellular carcinoma. Liver Cancer, 1, 2-14. https://doi.org/10.1159/000339016
  17. Kojima K, Takata A, Vadnais C, et al (2011). MicroRNA122 is a key regulator of alpha fetoprotein expression and influences the aggressiveness of hepatocellular carcinoma. Nat Commun, 2, 338. https://doi.org/10.1038/ncomms1345
  18. Lee SS, Shin HS, Kim HJ, et al (2012). Analysis of prognostic factors and 5-year survival rate in patients with hepatocellular carcinoma: a single-center experience. Korean J Hepatol, 18, 48-55. https://doi.org/10.3350/kjhep.2012.18.1.48
  19. Li MS, Li PF, Yang FY, et al (2002). The intracellular mechanism of alpha-fetoprotein promoting the proliferation of NIH 3T3 cells. Cell Res, 12, 151-6. https://doi.org/10.1038/sj.cr.7290121
  20. Li P, Wang SS, Liu H, et al (2011). Elevated serum alpha fetoprotein levels promote pathological progression of hepatocellular carcinoma. World J Gastroenterol, 17, 4563-71. https://doi.org/10.3748/wjg.v17.i41.4563
  21. Li T, Qin LX, Gong X, et al (2014). Clinical characteristics, outcome, and risk factors for early and late intrahepatic recurrence of female patients after curative resection of hepatocellular carcinoma. Surgery, 156, 651-60. https://doi.org/10.1016/j.surg.2014.04.008
  22. Meng W, Li X, Bai Z, et al (2014). Silencing alpha-fetoprotein inhibits VEGF and MMP-2/9 production in human hepatocellular carcinoma cell. PLoS One, 9, 90660. https://doi.org/10.1371/journal.pone.0090660
  23. Nakagawa K, Koike S, Matsumura H, et al (2012). Alphafetoprotein producing rectal cancer. Gan To Kagaku Ryoho, 39, 671-4.
  24. Nomura F, Ohnishi K, Tanabe Y (1989). Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels. Analysis of 606 patients. Cancer, 64, 1700-7. https://doi.org/10.1002/1097-0142(19891015)64:8<1700::AID-CNCR2820640824>3.0.CO;2-Z
  25. Ogden SK, Lee KC, Barton MC (2000). Hepatitis B viral transactivator HBx alleviates p53-mediated repression of alpha-fetoprotein gene expression. J Biol Chem, 275, 27806-14.
  26. Peng SY, Chen WJ, Lai PL, et al (2004). High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations. Int J Cancer, 112, 44-50. https://doi.org/10.1002/ijc.20279
  27. Sangiovanni A, Del Ninno E, Fasani P, et al (2004). Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance. Gastroenterology, 126, 1005-14. https://doi.org/10.1053/j.gastro.2003.12.049
  28. Savastano S, Miotto D, Casarrubea G, et al (1999). Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with Child's grade A or B cirrhosis: a multivariate analysis of prognostic factors. J Clin Gastroenterol, 28, 334-40. https://doi.org/10.1097/00004836-199906000-00010
  29. Sugita S, Sasaki A, Iwaki K, et al (2008). Prognosis and postoperative lymphocyte count in patients with hepatocellular carcinoma who received intraoperative allogenic blood transfusion: a retrospective study. Eur J Surg Oncol, 34, 339-45. https://doi.org/10.1016/j.ejso.2007.02.010
  30. Sung WK, Zheng H, Li S, et al (2012). Genomewide survey of recurrent HBV integration in hepatocellular carcinoma. Nat Genet, 44, 765-9. https://doi.org/10.1038/ng.2295
  31. Tomasi TB Jr (1977). Structure and function of alpha-fetoprotein. Annu Rev Med, 28, 453-65. https://doi.org/10.1146/annurev.me.28.020177.002321
  32. Yang X, Zhang Y, Zhang L, et al (2008). Silencing alphafetoprotein expression induces growth arrest and apoptosis in human hepatocellular cancer cell. Cancer Lett, 271, 281-93. https://doi.org/10.1016/j.canlet.2008.06.017
  33. Yu W, Rong W, Wang L et al (2014). R1 hepatectomy with exposure of tumor surface for centrally located hepatocellular carcinoma. World J Surg, 38, 1777-85. https://doi.org/10.1007/s00268-013-2429-3
  34. Yuen MF, Tanaka Y, Fong DY, et al (2009). Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B. J Hepatol, 50, 80-8. https://doi.org/10.1016/j.jhep.2008.07.023
  35. Zhang XF, Qi X, Meng B, et al (2010). Prognosis evaluation in alpha-fetoprotein negative hepatocellular carcinoma after hepatectomy: comparison of five staging systems. Eur J Surg Oncol, 36, 718-24. https://doi.org/10.1016/j.ejso.2010.05.022
  36. Zhou J, Yan T, Bi X, et al (2013). Evaluation of seven different staging systems for alpha-fetoprotein expression in hepatocellular carcinoma after hepatectomy. Tumor Biol, 34, 1061-70. https://doi.org/10.1007/s13277-013-0646-x

Cited by

  1. A comparison of the risk factors of intrahepatic recurrence, early recurrencen, and multiple recurrences after resection for single nodular hepatocellular carcinoma vol.19, pp.3, 2015, https://doi.org/10.14701/kjhbps.2015.19.3.89
  2. Subclassification of patients with solitary hepatocellular carcinoma based on post-hepatectomy survival: a large retrospective study vol.37, pp.4, 2016, https://doi.org/10.1007/s13277-015-4387-x
  3. MiR-494-3p promotes PI3K/AKT pathway hyperactivation and human hepatocellular carcinoma progression by targeting PTEN vol.8, pp.1, 2018, https://doi.org/10.1038/s41598-018-28519-2
  4. Prognostic role of alpha-fetoprotein response after hepatocellular carcinoma resection vol.6, pp.6, 2018, https://doi.org/10.12998/wjcc.v6.i6.110